Recombinant Naja atra Cytotoxin 6

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary based on purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. Request dry ice shipping in advance for an additional fee.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form shelf life is generally 6 months at -20°C/-80°C. Lyophilized form shelf life is generally 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during production. If you require a specific tag, please inform us, and we will prioritize developing it.
Synonyms
; Cytotoxin 6; Cardiotoxin 6; CTX6; Cardiotoxin A6; CTX A6; Cardiotoxin N; CTXN; Ctx-N; Cytotoxin N
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
22-81
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Naja atra (Chinese cobra)
Target Protein Sequence
LKCNQLIPP FYKTCAAGKN LCYKMFMVAA PKVPVKRGCI DVCPKSSLLV KYVCCNTDRC N
Uniprot No.

Target Background

Function
Basic protein that binds to cell membranes and depolarizes cardiomyocytes. This cytotoxin also exhibits lytic activity on various cells, including red blood cells. Interaction with membrane sulfatides induces pore formation and cell internalization, leading to cardiomyocyte cytotoxicity. Targets the mitochondrial membrane, causing swelling and fragmentation. Inhibits protein kinases C. Binds to integrin αVβ3 with moderate affinity.
Protein Families
Snake three-finger toxin family, Short-chain subfamily, Type IA cytotoxin sub-subfamily
Subcellular Location
Secreted. Target cell membrane.
Tissue Specificity
Expressed by the venom gland.

Q&A

What is the biochemical profile of Naja atra Cytotoxin 6 compared to other cytotoxins in cobra venom?

Naja atra Cytotoxin 6 is a member of the three-finger toxin (3FTx) family present in Chinese cobra venom. Like other cytotoxins (CTXs), it is a small (~7-8 kDa), basic, amphipathic protein that comprises approximately 45-50% of the total protein content in Naja atra venom .

Cytotoxins from Naja atra function primarily by disrupting cell membranes, leading to cell lysis and tissue necrosis. The biochemical profile distinguishing Cytotoxin 6 includes:

  • Molecular weight: approximately 7-8 kDa

  • Structure: Three-finger fold stabilized by four conserved disulfide bridges

  • Isoelectric point: Highly basic (pI >8.5)

  • Amino acid composition: Rich in positively charged residues (Lys, Arg) that facilitate interaction with negatively charged phospholipid membranes

  • Membrane-binding: Forms amphipathic structures that insert into lipid bilayers

When comparing cytotoxin abundance across different cobra species, Naja atra venom contains intermediate levels of cytotoxins, with some species like Naja nivea containing up to 75% cytotoxins, while others like Naja samarensis contain as little as 17% .

What experimental models are most appropriate for studying Naja atra Cytotoxin 6 activity?

Several experimental models have proven effective for studying the biological activities of Naja atra cytotoxins:

  • Cell culture models: The C2C12 myoblast cell line provides an ideal model to investigate cytotoxicity toward muscle tissue, as cobra venom has strong cytolytic effects that induce tissue necrosis in snakebite victims . Immortalized human keratinocytes (N/TERTs) are also employed to evaluate cross-reactivity of cytotoxins against various cobra venoms .

  • Membrane models: Artificial lipid bilayers and liposomes are used to study the membrane-disrupting properties of cytotoxins at the molecular level.

  • In vivo models: Murine models with intradermal venom administration can be used to assess dermonecrotic effects, though some neutralizing agents that work well in vitro may not significantly decrease lesion size in such models .

  • Cytotoxicity assays: LDH (lactate dehydrogenase) release assays provide quantitative measurements of cell membrane damage , while luminescent cell viability assays can evaluate neutralization activity of potential inhibitors .

Experimental ModelPurposeAdvantagesLimitations
C2C12 myoblast cellsEvaluating cytotoxicity on muscle cellsReproducible, quantifiableMay not reflect tissue complexity
N/TERT keratinocytesAssessing cytotoxicity on skin cellsHuman-derived, relevant to dermonecrosisLimited to cell-level responses
Artificial membranesStudying mechanism of membrane disruptionControlled compositionLacks cellular complexity
Murine dermonecrosis modelIn vivo assessment of tissue damagePhysiologically relevantHigher variability, ethical considerations

How do specific amino acid residues in the three loops of Naja atra Cytotoxin 6 determine its membrane-disrupting activity?

Research has identified specific amino acid residues within the three loops of cobra cytotoxins that significantly impact their membrane-disrupting properties. Analysis of available CT amino acid sequences has revealed a hierarchy of residues that interfere with cytotoxin incorporation into membranes :

  • Loop I (N-terminal): Pro9 is a critical residue that significantly reduces membrane activity

  • Loop II (central): Ser28 moderately reduces membrane activity

  • Loop III (C-terminal): Asn/Asp45 has the least impact on membrane activity

The hierarchical influence is: Pro9 > Ser28 > Asn/Asp45 .

Based on combinations of these special residues, cytotoxins can be divided into eight groups:

  • Group 1: Contains all three inhibitory residues (Pro9, Ser28, Asn/Asp45); exhibits lowest membrane activity

  • Group 8: Lacks all inhibitory residues; demonstrates highest membrane activity

For Naja atra Cytotoxin 6, the specific combination of these residues would determine its classification within this framework and predict its relative membrane activity. Researchers investigating structure-function relationships should analyze these key positions to understand the molecular basis of its cytotoxicity.

What are the current approaches for developing neutralizing antibodies or proteins against Naja atra cytotoxins?

Several innovative approaches are being explored to develop effective neutralizing agents against Naja atra cytotoxins:

  • Single-chain variable fragments (scFvs): Researchers have developed a chicken-derived scFv (S1) that specifically recognizes cytotoxin and neutralizes its cytotoxic effects on myoblasts. This scFv demonstrated 2-3 fold higher neutralization potency compared to conventional antivenom (3.81 mg/mg vs. 9.02 mg/mg for FNAV) .

  • De novo computational protein design: Recent advances in protein design have enabled the creation of binding proteins with high affinity and specificity without extensive experimental screening. Using RFdiffusion and ProteinMPNN, researchers have designed proteins that target the three-finger loops of cytotoxins. For example, a designed protein (CYTX) demonstrated binding to cytotoxins from multiple Naja species with a Kd of 271 nM for Naja pallida cytotoxin .

  • Consensus-based targeting: To increase neutralization breadth, researchers have targeted consensus sequences derived from multiple snake cytotoxins (e.g., Type IA cytotoxin sub-subfamily derived from 86 different snake cytotoxins) .

The designed cytotoxin binder (CYTX) provided 70-90% protection against venom-induced cytotoxicity when pre-incubated with venoms from seven different Naja species at a 1:5 molar ratio (toxin:binder) . The cross-reactivity potential of these neutralizing agents is particularly valuable, as antibodies developed against N. atra cytotoxins have shown recognition of cytotoxins from N. kaouthia and N. naja venoms .

What methodological approaches are recommended for recombinant expression and purification of Naja atra Cytotoxin 6?

For successful recombinant expression and purification of Naja atra Cytotoxin 6, the following methodological approaches are recommended:

  • Expression systems:

    • Escherichia coli: Most commonly used for recombinant toxin expression due to high yields and cost-effectiveness

    • Considerations: Cytotoxins lack post-translational modifications, making bacterial expression suitable

  • Expression strategies:

    • Fusion partners: Addition of solubility tags (e.g., SUMO, MBP, or thioredoxin) may improve folding and reduce toxicity to host cells

    • Codon optimization: Essential for efficient expression in heterologous systems

    • Inducible promoters: Tight regulation of expression to control potential toxicity

  • Purification methods:

    • Immobilized metal affinity chromatography (IMAC): Commonly used with His-tagged constructs

    • Size exclusion chromatography (SEC): Critical for obtaining monomeric populations with high purity

    • Reverse-phase high-performance liquid chromatography (RP-HPLC): Particularly effective for separating different cytotoxin isoforms

  • Quality control:

    • Mass spectrometry (LC-MS/MS): For confirmation of identity and purity

    • Circular dichroism (CD): To verify proper folding and assess thermostability

    • Functional assays: Cell-based cytotoxicity assays to confirm biological activity

Recombinant cytotoxins may differ from native forms by the presence of additional residues at the N-terminus , which should be considered when interpreting experimental results.

How can researchers assess the cytotoxic activity of recombinant Naja atra Cytotoxin 6 in vitro?

For robust assessment of cytotoxic activity, researchers should employ a multi-method approach:

  • LDH release assay: This assay measures lactate dehydrogenase released from damaged cells into culture medium, providing quantitative assessment of membrane integrity. C2C12 myoblast cells treated with Naja atra cytotoxins show significant LDH release, making this assay particularly suitable .

  • Cell viability assays:

    • MTT/MTS assays: Measure metabolic activity as an indicator of cell viability

    • Luminescent cell viability assays: Provide high sensitivity for evaluating neutralization activity of potential inhibitors

    • Flow cytometry with annexin V/PI staining: Distinguishes between apoptotic and necrotic cell death mechanisms

  • Morphological assessment: Treatment of C2C12 cells with Naja atra venom markedly alters cell morphology, reducing cell size and elongation . Microscopic evaluation provides valuable qualitative data to complement quantitative assays.

  • Calcium flux measurement: Monitoring intracellular Ca²⁺ release following cytotoxin exposure provides insights into early events in cytotoxicity mechanisms .

  • Membrane models: Artificial lipid bilayers can be used to directly observe membrane disruption using techniques such as calcein leakage assays or electrical impedance measurements.

Recommended protocol for LDH-based cytotoxicity assessment:

  • Seed cells (2×10⁴ cells/well) in 96-well plates and culture for 24h

  • Prepare serial dilutions of recombinant cytotoxin (0.1-100 μg/mL)

  • Treat cells for 4-24h depending on cell type

  • Collect supernatant and measure LDH activity using commercial kits

  • Calculate percentage cytotoxicity using appropriate controls

  • Determine EC₅₀ values using dose-response curve analysis

What challenges are commonly encountered when studying the structure-function relationship of Naja atra cytotoxins?

Researchers face several methodological challenges when investigating structure-function relationships of Naja atra cytotoxins:

  • Structural similarity among isoforms: Naja atra venom contains multiple cytotoxin isoforms with high sequence similarity, making it difficult to attribute specific functions to individual cytotoxins.

  • Membrane interaction complexity: The precise mechanism of membrane disruption involves multiple steps (binding, insertion, oligomerization), each influenced by different structural elements of the cytotoxin.

  • Model system limitations: In vitro models may not fully recapitulate the complexity of in vivo effects. For example, the designed cytotoxin binder CYTX provided protection in cell-based assays but did not significantly decrease dermonecrotic lesions in murine models .

  • Protein stability issues: Recombinant cytotoxins may demonstrate conformational differences compared to native toxins, affecting their functional properties. Researchers have addressed this by introducing disulfide bonds to reduce flexibility and improve thermal stability (e.g., CYTX_B10 with improved thermal stability, Tm= 70.3°C) .

  • Contamination with impurities: During purification, impurities may affect concentration calculations, potentially leading to overestimation of cytotoxin concentrations and underestimation of ED₅₀ values .

To address these challenges, researchers should:

  • Employ multiple complementary approaches to study membrane interactions

  • Validate findings across different model systems (cell types, membrane models)

  • Include appropriate controls to account for potential impurities

  • Consider both in vitro and in vivo models when evaluating neutralizing agents

How should researchers interpret contradictory findings regarding the mechanism of action of Naja atra cytotoxins?

When confronted with contradictory findings regarding cytotoxin mechanisms, researchers should consider:

  • Isoform heterogeneity: Naja atra venom contains multiple cytotoxin isoforms with varying activities. Discrepancies in research findings may result from studying different isoforms or mixtures.

  • Experimental model differences: Results from different cell lines, membrane models, or experimental conditions may yield apparently contradictory findings. For example:

    • C2C12 myoblasts may respond differently than N/TERT keratinocytes

    • Artificial membrane studies may not translate directly to cellular responses

    • Concentration-dependent effects may lead to different mechanisms at varying doses

  • Membrane composition effects: Cytotoxin activity is strongly influenced by membrane composition, particularly phospholipid content and charge. Variations in experimental membrane compositions contribute to seemingly contradictory results.

  • Multiple simultaneous mechanisms: Cytotoxins likely operate through multiple mechanisms simultaneously. Different studies may capture distinct aspects of a complex process.

When analyzing contradictory findings, researchers should systematically evaluate:

  • The specific cytotoxin isoform studied

  • Experimental methods and models employed

  • Concentration ranges examined

  • Membrane or cell types used

  • Temporal factors (acute vs. prolonged exposure)

What statistical approaches are most appropriate for analyzing dose-response data for cytotoxin activity?

For robust analysis of cytotoxin dose-response data, researchers should consider:

  • Nonlinear regression analysis: Four-parameter logistic regression (4PL) is commonly used to determine EC₅₀ values from dose-response curves, providing a robust fit for sigmoidal responses typical of cytotoxins.

  • Normalization procedures: Data should be normalized to appropriate controls (untreated cells for 0% cytotoxicity; completely lysed cells for 100% cytotoxicity).

  • Replication requirements: Minimum of three biological replicates with technical triplicates for each experiment to ensure statistical validity.

  • Statistical comparisons:

    • ANOVA with post-hoc tests (e.g., Tukey's test) for comparing multiple treatments

    • Student's t-test for binary comparisons

    • For neutralization studies, specialized statistical approaches such as isobologram analysis may be necessary to evaluate combination effects

  • Data presentation:

    • Include both raw data points and fitted curves

    • Report EC₅₀ values with 95% confidence intervals

    • For neutralization studies, calculate and report ED₅₀ values (amount of neutralizing agent required per unit of toxin)

When comparing neutralization potency, researchers should use standardized metrics. For example, in comparing the anti-CTX scFv S1 to conventional antivenom (FNAV), neutralization potency was expressed as mg of antibody required per mg of toxin (3.81 mg/mg vs. 9.02 mg/mg) .

How can computational design approaches enhance the development of cytotoxin neutralizing agents?

Computational design represents a promising frontier for developing effective neutralizing agents against Naja atra cytotoxins:

  • RFdiffusion and ProteinMPNN approaches: These computational tools have successfully created binding proteins targeting cytotoxin three-finger loops. Using secondary structure and block adjacency tensors to specify desired β-strand interactions, researchers have designed proteins that bind directly to cytotoxin loops .

  • Advantages of computational design:

    • Creation of binding proteins with high affinity and specificity without extensive experimental screening

    • Ability to custom design scaffolds to match almost any target shape

    • Generation of binders to loop regions of proteins, which are traditionally challenging targets

    • Design of stable, amenable to low-cost manufacturing proteins, crucial for addressing snakebite envenoming as a neglected tropical disease

  • Future opportunities:

    • Targeting consensus sequences across multiple cobra species to develop broadly neutralizing agents

    • Designing multi-specific binders that simultaneously target different toxin families

    • Optimizing affinity and stability for improved in vivo efficacy

    • Combining computational design with experimental validation to iteratively improve neutralizing agents

What emerging technologies show promise for studying the molecular interactions of Naja atra cytotoxins?

Several cutting-edge technologies hold promise for advancing our understanding of cytotoxin molecular interactions:

  • Cryo-electron microscopy (Cryo-EM): Enables visualization of cytotoxin-membrane interactions at near-atomic resolution, potentially revealing oligomerization and membrane insertion mechanisms.

  • Single-molecule techniques:

    • Atomic force microscopy (AFM) to visualize membrane disruption in real-time

    • Single-molecule FRET to monitor conformational changes upon membrane binding

    • Optical tweezers to measure forces involved in membrane disruption

  • Advanced structural biology approaches:

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map protein-membrane interfaces

    • Solid-state NMR to determine membrane-bound conformations of cytotoxins

    • X-ray crystallography of toxin-antibody complexes, as demonstrated with the CYTX_B10 design

  • High-throughput screening technologies:

    • Microfluidic systems for rapid evaluation of cytotoxicity and neutralization

    • Label-free biosensors for real-time interaction analysis

    • Automated image analysis for quantifying morphological changes in cells

  • Genomic and proteomic approaches:

    • Next-generation sequencing to identify novel cytotoxin variants

    • Proteomics analysis of cobra venoms to determine relative abundance of different cytotoxin isoforms

    • Temporal venom analysis to understand how venom composition changes with cobra age and environment

These technologies, combined with computational approaches, are expected to accelerate the development of effective neutralizing agents against Naja atra cytotoxins, potentially improving outcomes for snakebite victims.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.